Group 1 - EVE Energy signed a procurement framework agreement with its affiliate, Smoore International, for continuous procurement of battery cells starting from January 1, 2026 [1] - Zhaoyi Information plans to issue H-shares and list on the Hong Kong Stock Exchange [1] - Fuke Environmental announced a change in its stock abbreviation to "Fuke Technology" effective November 26 [1] Group 2 - Dajia Weikang's shareholder and director terminated a share reduction plan ahead of schedule, having reduced 1% of total shares [2] - Aohong Electronics received approval from the China Securities Regulatory Commission for the issuance of convertible bonds [2] - Yingfeng Environment's controlling shareholder plans to issue exchangeable bonds not exceeding 1 billion yuan [2] Group 3 - Longshen Rongfa's subsidiary obtained a renewed drug production license covering various pharmaceutical products [4] - Xinhua News' subsidiary invested 15 million yuan in a fund with a total commitment of 221 million yuan [5] - Guang'an Aizhong appointed two new deputy general managers [6] Group 4 - Fosun Pharma's subsidiary's drug for gastric cancer treatment was included in the breakthrough therapy program by the National Medical Products Administration [7] - Nanjiao Foods reported a significant decline in October net profit due to rising raw material costs [8] - Nanfeng Co. won two nuclear power project bids totaling 928.7 million yuan [10] Group 5 - Puluo Pharmaceutical received a drug registration certificate for its Cefdinir capsules [11] - Liming Co.'s subsidiary received environmental approval for a new pesticide raw material project [12] - Longhua New Materials' expansion project for polyether polyols has commenced trial production [13] Group 6 - Pumen Technology's products received IVDR CE certification from TÜV Rheinland [15] - China Chemical reported new contracts worth 312.67 billion yuan from January to October [18] - China Nuclear Construction achieved new contracts totaling 123.84 billion yuan as of October [19] Group 7 - Changshu Bank's executives plan to purchase at least 550,000 shares of the bank [20] - Shandong Steel's subsidiary is applying for bankruptcy liquidation to focus on core business [21] - Huakang Clean is expected to win a bid for a purification system project worth 176 million yuan [23] Group 8 - Huawu Co. plans to internally transfer subsidiary equity [24] - Tianen Kang's subsidiary received clinical trial acceptance for a new drug [26] - Tianyi Medical's subsidiary obtained a medical device registration certificate for a blood dialysis product [27] Group 9 - Xuelang Environment is facing a pre-restructuring application from creditors [27] - Chitianhua's subsidiary resumed production after passing safety inspections [28] - Huaping Co.'s director plans to reduce 0.03% of company shares [30] Group 10 - Xizhuang Co. plans to establish a wholly-owned subsidiary in Singapore [31] - Ruisheng Intelligent's subsidiary won a 60.23 million yuan ICT project bid [32] - Junyi Digital plans to invest 120 million yuan in Guanghong Precision [33] Group 11 - Fuguang Co.'s controlling shareholder plans to increase holdings between 80 million to 150 million yuan [34] - Ganyue Express reported a 13.68% increase in logistics revenue in October [39] - Jiangsu Sop terminated its 2025 private placement plan [41] Group 12 - Langke Intelligent's shareholders plan to reduce a total of 1.68% of company shares [42] - Yuantong Express reported an 8.97% increase in express product revenue in October [45] - Jinbei Automotive plans to invest 158 million yuan to acquire 52% of Zhongtuo Technology [46]

Core Viewpoint - Huakang Clean (301235.SZ) has recently participated in the bidding for the "Keqiao Future Medical Center Purification System Project" with a winning bid amount of 175,687,785.00 yuan [1] Group 1 - The bidding was conducted by Shaoxing Keqiao Future City Medical Project Construction Co., Ltd. [1] - The public announcement of the winning candidates was published on November 19, 2025, by the Zhejiang Provincial Public Resource Trading Service Platform [1]

Core Viewpoint - Huakang Clean (301235.SZ) has successfully become the first candidate for the bidding of the "Keqiao Future Medical Center Purification System Project" with a bid amount of 176 million yuan [1] Group 1 - The bidding was conducted by Shaoxing Keqiao Future City Medical Project Construction Co., Ltd. [1] - The company has been announced as the first candidate for the bid [1] - The winning bid amount is 176 million yuan [1]

Core Viewpoint - Huakang Clean (301235) has successfully participated in the bidding for the "Keqiao Future Medical Center Purification System Project" and has been announced as the first candidate for the bid with a winning price of 176 million yuan [1] Group 1 - The bidding was conducted by Shaoxing Keqiao Future City Medical Project Construction Co., Ltd. [1] - The company has been recognized as the top candidate in the public announcement of the bidding results [1] - The total bid amount won by the company is 176 million yuan [1]

Group 1 - The company Huakang Clean (301235) announced on November 20 that it has been pre-selected for the purification system project at Keqiao Future Medical Center with a bid price of 176 million yuan [1] - The project has a scheduled completion time of 240 calendar days [1]

转债代码：123251 转债简称：华医转债 证券代码：301235 证券简称：华康洁净 公告编号：2025-134 武汉华康世纪洁净科技股份有限公司 5、中标价：175,687,785.00 元 6、中标工期(日历天)：240 天，并不得影响总包总进度计划（以招标人发出 的开工指令为准，具体应与工程施工总进度计划同步，服从总包管理），以甲方 （监理人）书面排产通知日开始计算工期，按实际施工时间计算，中间暂停时间 不计算。 关于项目预中标的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示：本项目仍处于中标候选人公示阶段，获取中标通知书、签约等后 续工作尚具有一定不确定性，敬请广大投资者注意投资风险。武汉华康世纪洁净 科技股份有限公司（以下简称"公司"）将根据相关事项后续进展情况履行相应 的信息披露义务。 公司于近日参与了"柯桥未来医学中心净化系统项目"的投标，招标单位为 绍兴柯桥未来之城医学项目建设有限公司。2025 年 11 月 19 日，浙江省公共资源 交易服务平台（https://ggzy.zj.gov.cn）发布了相关中标候选人公示。 ...

Key Highlights - Company announcements include stock suspensions, project investments, and share buybacks [1][2] - Notable projects and contracts awarded to various companies [1] - Shareholding changes and planned reductions by major stakeholders [2] Group 1: Stock Suspensions and Regulatory Issues - 合富中国 (China Resources) will suspend trading for regulatory review [1] - 东百集团 (Dongbai Group) lacks duty-free operating qualifications and does not engage in duty-free goods business [1] Group 2: Project Investments - 璞泰来 (Putailai) plans to invest 2.5 billion yuan in a second phase of a film coating integration project [1] Group 3: Contracts and Awards - 浙江交科 (Zhejiang Jiaoke) is set to win an 1.836 billion yuan project [1] - 青龙管业 (Qinglong Pipe Industry) is pre-selected for the water supply project in 彭阳县 (Pengyang County) [1] Group 4: Share Transfers - 宏辉果蔬 (Honghui Fruits and Vegetables) intends to sell 100% equity in 福建宏辉 (Fujian Honghui) and 烟台宏辉 (Yantai Honghui) [1] - 电投能源 (Electric Investment Energy) plans to acquire 100% equity in 白音华煤电 (Baiyin Hua Coal Power) [1] - 漳州发展 (Zhangzhou Development) aims to acquire 30% equity in 信产集团 (Xinchang Group) [1] Group 5: Share Buybacks - 长春高新 (Changchun High-tech) has repurchased 0.95% of its shares, with the buyback period now concluded [1] Group 6: Shareholding Changes - 多名股东 of 滨江集团 (Binjiang Group) plan to reduce their holdings by up to 2.88% [2] - 康龙化成 (Kanglong Chemical) stakeholders intend to reduce their holdings by no more than 1.5% [2] Group 7: Other Financial Activities - 莱特光电 (Lite Optoelectronics) plans to issue convertible bonds to raise no more than 766 million yuan for digital upgrades of its production facilities [2] - 正丹股份 (Zhengdan Co.) has completed the acceptance of a project for 15,000 tons/year of high-performance specialty resin monomer series products [2]

Core Points - Huakang Clean announced on November 14 that it has been confirmed as the selected supplier for the "Wuyi New District Comprehensive Hospital (Phase I) Medical Special Construction and Installation Subcontract" project [2] Group 1 - The company disclosed the project pre-bid notice on October 25, 2025, on the ChiNext information disclosure website [2] - The selection was communicated through a notice from the bidding agency Fujian Huiyuan Engineering Consulting Co., Ltd. [2]

Group 1 - The core point of the article is that Huakang Clean (301235) has been confirmed as the selected supplier for the "Wuyi New District Comprehensive Hospital (Phase I) Medical Special Construction and Installation Subcontract" project, with a bid price of 100 million yuan, reflecting a discount of 13.50% [1] Group 2 - The announcement was made on November 14, indicating the company's successful bid in a competitive process [1] - The project is significant as it involves medical construction, which is a critical sector in the healthcare industry [1] - The involvement in this project may enhance the company's reputation and potential future opportunities in similar contracts [1]

Group 1 - The company Huakang Clean (301235.SZ) has been confirmed as the selected supplier for the "Wuyi New District Comprehensive Hospital (Phase I) Medical Special Construction and Installation Subcontract" project [1] - The winning bid amount for this project is 100 million yuan [1]